Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Sung Il | - |
dc.contributor.author | Kim, Soon Kil | - |
dc.contributor.author | Park, Sungha | - |
dc.contributor.author | Kim, Ju Han | - |
dc.contributor.author | Ihm, Sang Hyun | - |
dc.contributor.author | Kim, Gwang-Il | - |
dc.contributor.author | Kim, Woo Shik | - |
dc.contributor.author | Pyun, Wook Bum | - |
dc.contributor.author | Kim, Yu-Mi | - |
dc.contributor.author | Shin, Jin ho | - |
dc.date.accessioned | 2021-07-30T05:21:29Z | - |
dc.date.available | 2021-07-30T05:21:29Z | - |
dc.date.created | 2021-05-14 | - |
dc.date.issued | 2016-01 | - |
dc.identifier.issn | 2635-6325 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/4394 | - |
dc.description.abstract | Background Resistant hypertension (RH) may be one of the cause of the plateau in improving the control rate in hypertension (HT) management. The misdiagnosis of RH by clinic blood pressure (BP) is important clinical problem. Aim of the study were to investigate the prevalence of RH by ambulatory blood pressure monitoring (ABPM) and the factor associated with control status of ambulatory BPs. Methods For 1230 subjects taking one or more antihypertensive medication (AHM) enrolled in the Korean Ambulatory Blood Pressure Monitoring (Kor-ABP) registry, the prevalence of RH was calculated which was defined as uncontrolled BP by three AHM classes including diuretic or BP in need of four or more AHM classes. The prevalence determined by clinic versus ambulatory BP was compared. Results The age was 59.3 ± 12.5 years, and 44.3 % were female (n = 1230). Among them 72 subjects were taking three AHM drugs including diuretics and 105 subjects were taking four or more AHM classes. With uncontrolled daytime ambulatory BP in 41 among 72 subjects, prevalence of RH was 11.9 % (146/1230). By using nighttime BP criteria, there was significant difference in the prevalence of RH for clinic versus nighttime BP (146/177 vs. 159/177, p = 0.0124). For control status of daytime BP, masked uncontrolled BP was 16.9 % and controlled BP with white-coat effect was 14.1 %. For nighttime BP control status, odd ratios for smoking (0.624), drinking (1.512), coronary artery disease (0.604), calcium antagonist (1.705), and loop diuretics (0.454) were all significant. Conclusion The prevalence of RH was 11.9 % by daytime BP and it was significantly higher when using nighttime BP criteria. Control status of daytime BP was misclassified in 31.0 %. Smoking, drinking, coronary artery disease, calcium antagonist, and loop diuretics were associated with nighttime BP control status. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | Korean Society of Hypertension | BioMed Central | - |
dc.title | Prevalence of resistant hypertension and associated factors for blood pressure control status using Korean ambulatory blood pressure monitoring registry data | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, Jin ho | - |
dc.identifier.doi | 10.1186/s40885-016-0045-x | - |
dc.identifier.bibliographicCitation | Clinical Hypertension, v.22, no.8, pp.1 - 9 | - |
dc.relation.isPartOf | Clinical Hypertension | - |
dc.citation.title | Clinical Hypertension | - |
dc.citation.volume | 22 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 9 | - |
dc.type.rims | ART | - |
dc.type.docType | 정기학술지(Article(Perspective Article포함)) | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | other | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.